Cancer Immunology Research

Cancer Immunology Research英文簡介

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.

Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.

Cancer Immunology Research中文簡介

《Cancer Immunology Research》是一本由AMER ASSOC CANCER RESEARCH出版商出版的專業醫學期刊，該刊創刊于2013年，刊期12 issues/year，該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 1區，小類學科：免疫學 2區；腫瘤學 2區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋免疫學等領域，旨在及時、準確、全面地報道國內外免疫學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為12.02，

中科院分區最新升級版（當前數據版本：2021年12月最新升級版）

大類學科	分區	小類學科	分區	Top期刊	綜述期刊
醫學	1區	IMMUNOLOGY 免疫學 ONCOLOGY 腫瘤學	2區 2區	是	否

JCR分區（當前數據版本：2021-2022年最新版）

JCR分區等級	JCR所屬學科	分區	影響因子
Q1	IMMUNOLOGY	Q1	12.02
	ONCOLOGY	Q1

期刊指數

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
12.02	62	1.69%	96.40%	未開放	--

IF值(影響因子)趨勢圖